Skip to the main content
Drug Pricing Policies in the United States and Globally

Drug Pricing Policies in the United States and Globally

From Development to Delivery

A one-day conference exploring the current pharmaceutical pricing landscape. This event brings together leaders from the pharmaceutical industry, policymakers, legal practitioners, and scholars to engage in novel, interdisciplinary discussions to better understand current challenges and articulate best practices to address these issues. Participants assess the current challenges presented in drug pricing policy, from development to delivery, in both the United States and international context. We also explore and articulate best practices to expand access to medicines and develop a plan for disseminating these practices more widely.

 

See video and slides from this event here

 

Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and Global Access in Action at the Berkman Klein Center for Internet and Society at Harvard University, with support from Gilead Sciences, Inc.

Agenda (in development)

8:00 - 8:30am, Registration

8:30 - 8:45am, Welcome Remarks

  • I. Glenn Cohen, James A. Attwood and Leslie Williams Professor of Law and Faculty Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School

  • Quentin Palfrey, co-Director, Global Access in Action, Berkman Klein Center for Internet and Society at Harvard University

8:45 - 9:30am, Keynote Address

9:30 - 10:45am, Panel I: From Development to Delivery in the United States

  • Peter B. BachDirector, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center

  • Surya Singh, Vice President and Chief Medical Officer, Specialty Pharmacy, CVS Health

  • Michael Caljouw, Vice President, State Government and Regulatory Affairs, Blue Cross Blue Shield of Massachusetts

  • Moderator: Carmel Shachar, Executive Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and Lecturer at Law, Harvard Law School

10:45 - 11:00am, Break

11:00am - 12:15pm, Panel II: From Development to Delivery Globally

  • Amy Flood, Senior Vice President, Public Affairs, Gilead Sciences, Inc.

  • Lauren Galinsky, PIH’s Senior Clinical Operations Advisor, Partners in Health

  • Hannah Kettler, Senior Program Officer on the Life Sciences Partnerships team at the Bill and Melinda Gates Foundation

  • Tsveta Milanova, Senior Vice President, Global Value, Access and Policy, Alexion

  • Moderator: Quentin Palfrey, co-Director, Global Access in Action, Berkman Klein Center for Internet and Society at Harvard University

12:15 - 12:45pm, Keynote Address

  • Daniel BestSenior Advisor to the Secretary for Drug Pricing Reform, Food and Drug Administration, U. S. Department of Health and Human Services

12:45 - 1:45pm, Networking Lunch

1:45 - 3:00pm, Panel III: Best Practices in Pricing Policy for Essential Drugs

  • Peter B. BachDirector, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center

  • Annette Gaudino, HIV/HCV Project Co-Director, Treatment Action Group (TAG)
  • Aaron S. Kesselheim, Director, Program on Regulation, Therapeutics, and Law (PORTAL), Brigham & Women’s Hospital, and Associate Professor of Medicine, Harvard Medical School

  • Jami Taylor, Managing Director, Stanton Park Capital

  • Moderator: William W. FisherWilmerHale Professor of Intellectual Property Law, Harvard Law School, and Faculty Director, Berkman Klein Center for Internet and Society at Harvard University

3:00 - 3:30pm, Keynote Address

  • Joe Grogan, Associate Director, Health Programs, Office of Management and Budget

3:30 - 3:45pm, Break

3:45 - 4:30pm, Panel IV: Innovations in Drug Delivery and Policy

  • Sara Gerke, Research Fellow in Precision Medicine, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard Law School

  • Muhammad ZamanProfessor, Biomedical Engineering, Boston University

  • Moderator: Ashveena GajeeleeResearch Fellow, Global Access in Action, Berkman Klein Center for Internet and Society at Harvard University

Register

This event is free and open to the public, but seating is limited and registration is required. Register now!

Sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School and Global Access in Action at the Berkman Klein Center for Internet and Society at Harvard University. 

Past Event
Wednesday, October 24, 2018
Time
8:00 AM - 4:30 PM ET
Location
HLS Wasserstein Hall, Milstein East (room 2036, second floor)
1585 Massachusetts Ave
Cambridge, MA 02138 US

You might also like


Projects & Tools 01

Global Access in Action

Global Access in Action, a project of the Berkman Klein Center for Internet & Society at Harvard University, conducts action-oriented research into access to lifesaving medicines,…